Dublin, Sept. 14, 2017 -- The "Plasmapheresis Market - Global Opportunity Analysis and Industry Forecasts to 2022" report has been added to Research and Markets' offering.
Global plasmapheresis market is expected to reach USD 1,285.3 million by 2022 supported by a CAGR of 8.3% during the forecast period of 2017 to 2022.
The growth in this market is majorly driven by increasing incidence & prevalence of various autoimmune disorders, rising demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. However, high cost of plasmapheresis procedure and lack of awareness about plasmapheresis will hamper the growth of this market to some extent during the forecast period.
Key questions answered in the report:
- Which are the high growth market segments in terms of product type, technology, application, end user and regions/countries?
- What is the historical market for plasmapheresis across the globe?
- What are the market forecasts and estimates from the period 2015-2022?
- What are the major drivers, restraints, opportunities and trends in the global plasmapheresis market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the recent developments in the global plasmapheresis market?
- What are the different strategies adopted by the major players in the global plasmapheresis market?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the global plasmapheresis market and how do they compete with the global players?
Key Topics Covered:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Incidence of Autoimmune Diseases
4.2.1.2. Increasing Demand for Source Plasma from Biopharmaceutical Companies
4.2.1.3. Favorable Reimbursement Policies for Plasmapheresis Procedures
4.2.2. Restraints
4.2.2.1. High Cost of Plasmapheresis Devices & Procedures
4.2.2.2. Lack of Awareness About Plasmapheresis Procedures
4.2.2.3. Risk Associated with Plasmapheresis Procedures
4.2.3. Opportunity
4.2.3.1. Rising Demand for Plasmapheresis from Emerging Countries
4.3. Market Share Analysis, by Key Players
5. Plasmapheresis Market, By Product Type
5.1. Introduction
5.2. Instruments
5.3. Disposables
6. Plasmapheresis Market, By Technology
6.1. Introduction
6.2. Membrane Filtration
6.3. Centrifugation
7. Plasmapheresis Market, By Application
7.1. Introduction
7.2. Therapeutic Plasmapheresis
7.3. Source Plasma Collection
8. Plasmapheresis Market, By End User
8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Others
9. Geographic Analysis
9.1. Introduction
9.2. North America
9.3. Europe
9.4. Asia-Pacific
9.5. Rest of The World
10. Company Profiles
10.1. Asahi Kasei Corporation
10.2. Terumo Corporation
10.3. Baxter International Inc.
10.4. B. Braun Melsungen Ag
10.5. Kawasumi Laboratories Inc.
10.6. Kaneka Corporation
10.7. Haemonetics Corporation
10.8. Fresenius Se & Co. Kgaa
10.9. Shanghai Dahua Medical Apparatus Co., Ltd.
10.10. Infomed Sa
11. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/cw2gz5/plasmapheresis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Blood Banking


Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
First Western Ship Transits Strait of Hormuz Since Iran War Began
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Britain Courts Anthropic Amid US Defense Department Dispute
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 



